TWi launches AIDS drug generic following US court ruling

30-07-2015

TWi launches AIDS drug generic following US court ruling

Sebastian Duda / Shutterstock.com

TWi Pharmaceuticals has released a generic version of the Megace ES (megestrol acetate) drug, which is used to treat certain symptoms experienced by AIDS patients, just one day after a court ruled that it did not infringe a patent owned by Par Pharmaceutical.


TWi Pharmaceuticals; Par Pharmaceutical; AIDS; Megace ES; ANDA; US District Court for the District of Maryland; generics

LSIPR